Vertaling van "outcomes in high-risk " (Frans → Nederlands) :

Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.

D’après The ALLHAT Officers and Coordinators for the ALLAHT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.
L.M.H.Wing et al.: A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly.

To asses the effects of poorer outcomes, we added the peri-procedural mortality of low volume centres in the US, using the observed risk ratio of death to the risks of stroke or death; low volume centres showed a 1.8 times higher peri-procedural mortality. 50
To asses the effects of poorer outcomes, we added the peri-procedural mortality of low volume centres in the US, using the observed risk ratio of death to the risks of stroke or death; low volume centres showed a 1.8 times higher peri-procedural mortality.[50]

¤ chaque fois, les termes de recherche suivants ont été utilisés : [risk stratification pregnancy], [low risk pregnancy], [high risk pregnancy], ou [risicostratificatie zwangerschap], [laagrisicozwangerschap], [hoogrisicozwangerschap] pour les sites néerlandophones.
Telkens werden de volgende zoektermen gehanteerd: [risk stratification pregnancy], [low risk pregnancy], [high risk pregnancy], of [risicostratificatie zwangerschap], [laagrisicozwangerschap], [hoogrisicozwangerschap] in geval van Nederlandstalige sites.

Egiziano G, Pilote L, Behlouli H et al. Improved outcomes in heart failure treated with high-dose
10. Egiziano G, Pilote L, Behlouli H et al. Improved outcomes in heart failure treated with high-dose

54% of referred patients were excluded from the trial and sent directly forward to PCAS because they had a „prohibitive high risk‰. 38 It is unclear who this population might conceivably be, as the risk in the SAPPHIRE trial is low compared to the NASCET and ACE (CEA-) trials.
54% of referred patients were excluded from the trial and sent directly forward to PCAS because they had a „prohibitive high risk‰.38 It is unclear who this population might conceivably be, as the risk in the SAPPHIRE trial is low compared to the NASCET and ACE (CEA-) trials.

46. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease.
cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease.

Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B et al. Benazepril plus amlodipine or hydrochlorothiazide for hyprtension in high risk patients.
Minerva 2010; 9:88-9. Bespreking van: Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B et al. Benazepril plus amlodipine or hydrochlorothiazide for hyprtension in high risk patients.

29. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.
30. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.

28. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients.
carotid-artery stenting versus endarterectomy in high-risk patients.